Acute antagonism in three-drug combinations for vaginal HIV prevention in humanized mice by Philippe A. Gallay, Christina M. Ramirez, Marc M. Baum

Get full text

Cyclophilin Inhibitors Remodel the Endoplasmic Reticulum of HCV-Infected Cells in a Unique Pattern Rendering Cells Impervious to a Reinfection. by Udayan Chatterji, Michael Bobardt, Lana Schaffer, Malcolm Wood, Philippe A Gallay

Get full text

Characterization of the Anti-HCV Activities of the New Cyclophilin Inhibitor STG-175. by Philippe A Gallay, Udayan Chatterji, Michael D Bobardt, Zhengyu Long, Shengli Zhang, Zhuang Su

Get full text

HCV core residues critical for infectivity are also involved in core-NS5A complex formation. by Katarzyna Gawlik, James Baugh, Udayan Chatterji, Precious J Lim, Michael D Bobardt, Philippe A Gallay

Get full text

The combination of the NS5A and cyclophilin inhibitors results in an additive anti-HCV inhibition in humanized mice without development of resistance. by Michael Bobardt, Christina M Ramirez, Marc M Baum, Daren Ure, Robert Foster, Philippe A Gallay

Get full text

Correlation of Naturally Occurring HIV-1 Resistance to DEB025 with Capsid Amino Acid Polymorphisms by Brigitte Rosenwirth, Jean-Maurice Dumont, Grégoire Vuagniaux, Michael D. Bobardt, Philippe A. Gallay, Roger G. Ptak

Get full text

The Novel Cyclophilin Inhibitor CPI-431-32 Concurrently Blocks HCV and HIV-1 Infections via a Similar Mechanism of Action. by Philippe A Gallay, Michael D Bobardt, Udayan Chatterji, Daniel J Trepanier, Daren Ure, Cosme Ordonez, Robert Foster

Get full text

Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice by Jeremy R. A. Paull, Carolyn A. Luscombe, Alex Castellarnau, Graham P. Heery, Michael D. Bobardt, Philippe A. Gallay

Get full text

The inhibitor apoptosis protein antagonist Debio 1143 Is an attractive HIV-1 latency reversal candidate. by Michael Bobardt, Joseph Kuo, Udayan Chatterji, Sumit Chanda, Susan J Little, Norbert Wiedemann, Gregoire Vuagniaux, Philippe A Gallay

Get full text

Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice. by Philippe A Gallay, Udayan Chatterji, Aaron Kirchhoff, Angel Gandarilla, Manjula Gunawardana, Richard B Pyles, Mark A Marzinke, John A Moss, Marc M Baum

Get full text

HSV neutralization by the microbicidal candidate C5A. by Lot de Witte, Michael D Bobardt, Udayan Chatterji, Freek B van Loenen, Georges M G M Verjans, Teunis B H Geijtenbeek, Philippe A Gallay

Get full text

Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance study by Manjula Gunawardana, Simon Webster, Sofia Rivera, John M. Cortez, Jessica Breslin, Cristian Pinales, Christopher Buser, F. Javier Ibarrondo, Otto O. Yang, Michael Bobardt, Philippe A. Gallay, Amy P. Adler, Christina M. Ramirez, Peter A. Anton, Marc M. Baum

Get full text

Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV Prophylaxis by Manjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, Simon Webster, Patricia Galvan, Rob Fanter, Amalia E. Castonguay, Paul Webster, John A. Moss, Joseph Kuo, Philippe A. Gallay, Kathleen L. Vincent, Massoud Motamedi, Dana Weinberger, Mark A. Marzinke, Mark A. Marzinke, Craig W. Hendrix, Marc M. Baum

Get full text

Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxis by Manjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, Simon Webster, Amalia E. Castonguay, Paul Webster, Christopher Buser, John A. Moss, MyMy Trinh, Martin Beliveau, Craig W. Hendrix, Mark A. Marzinke, Michael Tuck, Richard M. Caprioli, Michelle L. Reyzer, Joseph Kuo, Philippe A. Gallay, Marc M. Baum

Get full text